Display options
Share it on

BMJ Sex Reprod Health. 2021 Jul 28; doi: 10.1136/bmjsrh-2021-201064. Epub 2021 Jul 28.

Comparison of postal and non-postal post-vasectomy semen sample submission strategies on compliance and failures: an 11-year analysis of the audit database of the Association of Surgeons in Primary Care of the UK.

BMJ sexual & reproductive health

Melanie Atkinson, Gareth James, Katie Bond, Zoe Harcombe, Michel Labrecque

Affiliations

  1. Sexual & Reproductive Health, Aneurin Bevan University Health Board, Newport, UK [email protected].
  2. Audit Lead for Association of Surgeons in Primary Care (ASPC), Rugby, UK.
  3. Palliative Care, Aneurin Bevan University Health Board, Newport, UK.
  4. Independent Researcher, Newport, UK.
  5. Department of Family and Emergency Medicine Laval University and Research Center, CHU de Québec-Université Laval, Quebec, Quebec, Canada.

PMID: 34321257 DOI: 10.1136/bmjsrh-2021-201064

Abstract

BACKGROUND: Vasectomy occlusive success is defined by the recommendation of 'clearance' to stop other contraception, and is elicited by post-vasectomy semen analysis (PVSA). We evaluated how the choice of either a postal or non-postal PVSA submission strategy was associated with compliance to PVSA and effectiveness of vasectomy.

METHODS: We studied vasectomies performed in the UK from 2008 to 2019, reported in annual audits by Association of Surgeons in Primary Care members. We calculated the difference between the two strategies for compliance with PVSA, and early and late vasectomy failure. We determined compliance by adding the numbers of men with early failure and those given clearance. We performed stratified analyses by the number of test guidance for clearance (one-test/two-test) and the study period (2008-2013/2014-2019).

RESULTS: Among 58 900 vasectomised men, 32 708 (56%) and 26 192 (44%) were advised submission by postal and non-postal strategies, respectively. Compliance with postal (79.5%) was significantly greater than with non-postal strategy (59.1%), the difference being 20.4% (95% CI 19.7% to 21.2%). In compliant patients, overall early failure detection was lower with postal (0.73%) than with non-postal (0.94%) strategy (-0.22%, 95% CI -0.41% to -0.04%), but this difference was neither clinically nor statistically significant with one-test guidance in 2014-2019. There was no difference in late failure rates.

CONCLUSIONS: Postal strategy significantly increased compliance to PVSA with similar failure detection rates. This resulted in more individuals receiving clearance or early failure because of the greater percentage of postal samples submitted. Postal strategy warrants inclusion in any future guidelines as a reliable and convenient option.

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Keywords: contraceptive agents; contraceptive effectiveness; family planning services; male; reproductive; sterilization

Conflict of interest statement

Competing interests: None declared.

Publication Types